查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984998

2026年全球钆基造影剂市场报告

Gadolinium-Based Contrast Agents Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，钆基造影剂的市场规模显着扩大。预计该市场规模将从2025年的18.8亿美元成长到2026年的20亿美元，复合年增长率（CAGR）为6.7%。过去几年成长要素包括：磁振造影（MRI）的广泛应用、慢性疾病负担的加重、对疾病早期诊断需求的不断增长、医院放射科的扩建以及造影增强成像技术的日益普及。

预计未来几年，钆基造影剂市场将维持强劲成长，到2030年市场规模将达到25.7亿美元，复合年增长率（CAGR）为6.4%。预测期内的成长主要归因于以下因素：需要进行诊断影像的患者数量不断增加、医疗基础设施投资不断扩大、门诊影像中心数量上升、MRI扫描的保险覆盖范围扩大以及对疾病早期筛检的日益重视。预测期内的关键趋势包括：磁振造影（MRI）造影剂化学技术的进步、更安全的钆製剂研发的拓展、大环钆造影剂的开发、低剂量造影技术的创新以及人工智慧（AI）影像分析系统的进步。

磁振造影（MRI）扫描数量的不断增长预计将推动钆基造影磁振造影市场的成长。 MRI是一种非侵入性诊断方法，它利用强磁场和无线电波产生内部器官和组织的详细影像。 MRI扫描数量的成长主要归因于全球人口老化加剧。老年人慢性病发病率较高，因此，精准的非侵入性软组织影像对于准确诊断和製定治疗方案至关重要。钆基造影剂能够提高MRI扫描的准确性，增强血管、肿瘤和发炎组织的显影效果，从而支持更准确的临床评估和决策。例如，根据英国公共医疗保健系统NHS英格兰的数据，截至2024年12月，英格兰的MRI扫描次数从2023年8月的361,705次增加到2024年8月的365,270次，2023年9月至2024年8月的12个月累计扫描次数达到1504,505次。因此，MRI扫描次数的增加正在推动钆基造影剂市场的成长。

在钆基造影剂市场主要企业正致力于开发先进的产品特性，例如具有增强弛豫特性的高稳定性大环造影剂，以提高病患安全性和诊断影像品质。具有增强弛豫特性的高稳定性大环造影剂是一种具有环状螯合结构的造影分子，能够牢固地结合钆离子，从而产生更强的磁振造影讯号，同时最大限度地降低金属解离的风险。这使得在减少钆用量的情况下也能获得更清晰的影像，在保持或提高影像清晰度的同时，也解决了安全问题。例如，2023年2月，总部位于法国的医学影像公司Guerbet LLC宣布其Elcirem（钆苦醇）注射剂正式上市，并开始首次用于病患。 Elcirem是首个具有同类最佳弛豫特性的高稳定性大环钆造影造影，能够以传统钆一半的剂量，为2岁及以上成人和儿童提供高品质的影像，用于检测大脑、脊髓及相关组织的病变。此外，这种造影剂透过促进质子弛豫来增强病灶与周围组织之间的对比度，代表了神经放射成像领域的一项重大进步。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球钆基造影剂市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 先进的诊断影像技术
    • 个性化诊断方案
    • 支持微创手术
    • 加强病人安全通讯协定
    • 造影剂的快速发展

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 门诊手术中心
  • 专科诊所
  • 研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球钆基造影剂市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球钆基造影剂市场规模、对比及成长率分析
  • 全球钆基造影剂市场表现：规模与成长，2020-2025年
  • 全球钆基造影剂市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 线性钆造影剂，大环钆造影剂
  • 磁振造影（MRI）检查的类型
  • 对比造影磁振造影（MRI）、心臟磁振造影（MRI）、功能性磁振造影（MRI）、全身筛检磁振造影（MRI）
  • 透过使用
  • 磁振造影（MRI）、磁振造影血管血管造影术（MRA）及其他应用
  • 最终用户
  • 医院、诊断中心、门诊手术中心和其他最终用户
  • 按类型细分：线性钆造影剂
  • 离子型线性钆造影剂，非离子型线性钆造影剂
  • 按类型细分：大环钆造影剂
  • 离子型大环钆造影剂，非离子型大环钆造影剂

第十章 区域与国别分析

  • 全球钆基造影剂市场：按地区划分，实际结果与预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球钆基造影剂市场：依国家划分，实际值及预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 钆基造影剂市场：竞争格局与市场占有率（2024年）
  • 钆基造影剂市场：公司评估矩阵
  • 钆基造影剂市场：公司简介
    • Bayer AG
    • Siemens Healthineers
    • Medline Imaging Pvt. Ltd.
    • GE HealthCare Technologies Inc.
    • United Imaging Healthcare

第37章 其他大型企业和创新企业

  • JB Chemicals & Pharmaceuticals Ltd., iMax Diagnostic Imaging Ltd., Zhejiang Starry Pharmaceutical Co. Ltd., Trivitron Diagnostic Imaging R&D, Canon Medical Systems Corporation, Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Vision Pharma Pvt. Ltd., Livealth Biopharma Pvt. Ltd., China Resources Zizhu Pharmaceutical Co. Ltd., Kiran Medical Systems Ltd., Unispire Biopharma Pvt. Ltd.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家、细分市场与策略

  • 2030年钆基造影剂市场：提供新机会的国家
  • 2030年钆基造影剂市场：充满新机会的细分市场
  • 2030年钆基造影剂市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH5MGBCA01_G26Q1

Gadolinium-based contrast agents are specialized medical formulations that contain gadolinium ions and are used to enhance the clarity and contrast of tissues during magnetic resonance imaging. Their purpose is to improve the visualization of abnormalities, blood flow, and organ structures, enabling healthcare professionals to produce more accurate diagnostic images.

The main types of gadolinium-based contrast agents include linear and macrocyclic contrast agents. Linear contrast agents contain gadolinium ions in an open-chain structure, improving MRI clarity by enhancing visualization of tissues and blood vessels. MRI procedure types include enhanced scans, cardiac MRI, functional MRI, and whole-body screening. Applications include MRI and MR angiography, with key end users such as hospitals, diagnostic centers, ambulatory surgical centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the gadolinium-based contrast agent market by increasing import costs for raw gadolinium and advanced chemical components, affecting production timelines and pricing. high-cost segments such as macrocycle gadolinium agents and specialized mri procedures in regions like north america and europe are most impacted. however, tariffs have encouraged local manufacturing and sourcing diversification, potentially fostering domestic innovation and reducing dependency on international supply chains.

The gadolinium-based contrast agents market research report is one of a series of new reports from The Business Research Company that provides gadolinium-based contrast agents market statistics, including gadolinium-based contrast agents industry global market size, regional shares, competitors with a gadolinium-based contrast agents market share, detailed gadolinium-based contrast agents market segments, market trends and opportunities, and any further data you may need to thrive in the gadolinium-based contrast agents industry. This gadolinium-based contrast agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gadolinium-based contrast agents market size has grown strongly in recent years. It will grow from $1.88 billion in 2025 to $2.00 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing use of magnetic resonance imaging scans, rising burden of chronic diseases, growing demand for early disease diagnosis, expanding hospital radiology departments, and increasing adoption of contrast-enhanced imaging.

The gadolinium-based contrast agents market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2030at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising patient volume requiring diagnostic imaging, increasing investments in healthcare infrastructure, a growing number of outpatient imaging centers, expanding insurance coverage for magnetic resonance imaging procedures, and increasing emphasis on early disease screening. Major trends in the forecast period include advancements in magnetic resonance imaging contrast chemistry technologies, increasing research and development in safer gadolinium formulations, development of macrocyclic gadolinium-based contrast agents, innovation in low-dose contrast technologies, and advancement in artificial intelligence-supported imaging analysis systems.

The rising number of magnetic resonance imaging (MRI) scans is expected to propel the growth of the gadolinium-based contrast agents market going forward. Magnetic resonance imaging (MRI) scans are non-invasive diagnostic procedures that use strong magnetic fields and radio waves to generate detailed images of internal organs and tissues. The increasing volume of MRI scans is largely driven by the expanding global geriatric population, which has a higher incidence of chronic diseases requiring precise, non-invasive soft-tissue imaging for accurate diagnosis and treatment planning. Gadolinium-based contrast agents enhance MRI scans by improving the visualization of blood vessels, tumors, and inflamed tissues, thereby supporting more accurate clinical assessment and decision-making. For instance, in December 2024, according to NHS England, a UK-based publicly funded healthcare system, the number of MRI scans in England rose from 361,705 in August 2023 to 365,270 in August 2024, with a rolling 12-month total from September 2023 to August 2024 reaching 4,504,615 scans. Therefore, the rising number of MRI scans is driving the growth of the gadolinium-based contrast agents market.

Major companies operating in the gadolinium-based contrast agents market are focusing on developing advanced product features, such as highly stable macrocyclic agents with elevated relaxivity, to enhance patient safety and improve diagnostic image quality. Highly stable macrocyclic agents with elevated relaxivity are contrast molecules constructed with ring-shaped chelating structures that tightly bind gadolinium ions, minimizing the risk of metal dissociation while generating stronger magnetic resonance signals. This allows for clearer imaging at lower gadolinium doses, addressing safety concerns while maintaining or improving image clarity. For example, in February 2023, Guerbet LLC, a France-based medical imaging company, announced the commercial launch and first patient dosing of Elucirem (gadopiclenol) injection. Elucirem is the first highly stable macrocyclic gadolinium-based contrast agent with the highest relaxivity in its class, enabling use at half the conventional gadolinium dose while delivering high-quality images for detecting lesions in the brain, spine, and associated tissues in adults and children aged two years and older. The agent also enhances contrast between lesions and surrounding tissues by accelerating proton relaxation, representing a significant advancement for neuroradiology imaging.

In September 2024, Zydus Lifesciences Ltd., an India-based innovation-driven healthcare company, entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals Co. Ltd. to commercialize gadolinium-based MRI contrast agents in the US market. Under the terms of the agreement, Viwit Pharmaceuticals will be responsible for the abbreviated new drug application (ANDA) submission, manufacturing, and supply of gadobutrol injection (generic GADAVIST) and gadoterate meglumine injection (generic DOTAREM). Zydus Lifesciences will exclusively market, distribute, and sell these products in the United States following regulatory approval. This collaboration strengthens Zydus' presence in the US diagnostic imaging segment while leveraging Viwit's development and manufacturing capabilities to expand access to cost-effective gadolinium-based contrast agents.

Major companies operating in the gadolinium-based contrast agents market are Bayer AG, Siemens Healthineers, Medline Imaging Pvt. Ltd., GE HealthCare Technologies Inc., United Imaging Healthcare, J.B. Chemicals & Pharmaceuticals Ltd., iMax Diagnostic Imaging Ltd., Zhejiang Starry Pharmaceutical Co. Ltd., Trivitron Diagnostic Imaging R&D, Canon Medical Systems Corporation, Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Vision Pharma Pvt. Ltd., Livealth Biopharma Pvt. Ltd., China Resources Zizhu Pharmaceutical Co. Ltd., Kiran Medical Systems Ltd., Unispire Biopharma Pvt. Ltd.

North America was the largest region in the gadolinium-based contrast agents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gadolinium-based contrast agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gadolinium-based contrast agents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gadolinium-based contrast agents market consists of sales of gadolinium-containing contrast media used to enhance the visibility of internal organs, tissues, and blood vessels during magnetic resonance imaging procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gadolinium-Based Contrast Agents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gadolinium-based contrast agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gadolinium-based contrast agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gadolinium-based contrast agents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Linear Gadolinium-Based Contrast Agents; Macrocycle Gadolinium-Based Contrast Agents
  • 2) By Magnetic Resonance Imaging (MRI) Procedure Type: Enhanced Magnetic Resonance Imaging (MRI) Scans; Cardiac Magnetic Resonance Imaging (MRI); Functional Magnetic Resonance Imaging (MRI); Whole-Body Screening Magnetic Resonance Imaging (MRI)
  • 3) By Application: Magnetic Resonance Imaging (MRI); Magnetic Resonance Angiography (MRA); Other Application
  • 4) By End-User: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Linear Gadolinium-Based Contrast Agents: Ionic Linear Gadolinium-Based Contrast Agents; Non Ionic Linear Gadolinium-Based Contrast Agents
  • 2) By Macrocycle Gadolinium-Based Contrast Agents: Ionic Macrocycle Gadolinium-Based Contrast Agents; Non Ionic Macrocycle Gadolinium-Based Contrast Agents
  • Companies Mentioned: Bayer AG; Siemens Healthineers; Medline Imaging Pvt. Ltd.; GE HealthCare Technologies Inc.; United Imaging Healthcare; J.B. Chemicals & Pharmaceuticals Ltd.; iMax Diagnostic Imaging Ltd.; Zhejiang Starry Pharmaceutical Co. Ltd.; Trivitron Healthcare Pvt. Ltd.; Trivitron Diagnostic Imaging R&D; Canon Medical Systems Corporation; Beijing Beilu Pharmaceutical Co. Ltd.; Unijules Life Sciences Ltd.; Unijules Life Sciences Ltd.; Vision Pharma Pvt. Ltd.; Livealth Biopharma Pvt. Ltd.; Livealth Biopharma Pvt. Ltd.; China Resources Zizhu Pharmaceutical Co. Ltd.; Kiran Medical Systems Ltd.; Unispire Biopharma Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Gadolinium-Based Contrast Agents Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Gadolinium-Based Contrast Agents Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Gadolinium-Based Contrast Agents Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Gadolinium-Based Contrast Agents Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advanced Imaging Techniques
    • 4.2.2 Personalized Diagnostic Solutions
    • 4.2.3 Minimally Invasive Procedure Support
    • 4.2.4 Enhanced Patient Safety Protocols
    • 4.2.5 Rapid Contrast Agent Development

5. Gadolinium-Based Contrast Agents Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Clinics
  • 5.5 Research Institutes

6. Gadolinium-Based Contrast Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gadolinium-Based Contrast Agents Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Gadolinium-Based Contrast Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Gadolinium-Based Contrast Agents Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Gadolinium-Based Contrast Agents Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Gadolinium-Based Contrast Agents Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gadolinium-Based Contrast Agents Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gadolinium-Based Contrast Agents Market Segmentation

  • 9.1. Global Gadolinium-Based Contrast Agents Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Linear Gadolinium-Based Contrast Agents, Macrocycle Gadolinium-Based Contrast Agents
  • 9.2. Global Gadolinium-Based Contrast Agents Market, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enhanced Magnetic Resonance Imaging (MRI) Scans, Cardiac Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging (MRI), Whole-Body Screening Magnetic Resonance Imaging (MRI)
  • 9.3. Global Gadolinium-Based Contrast Agents Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA), Other Application
  • 9.4. Global Gadolinium-Based Contrast Agents Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
  • 9.5. Global Gadolinium-Based Contrast Agents Market, Sub-Segmentation Of Linear Gadolinium-Based Contrast Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ionic Linear Gadolinium-Based Contrast Agents, Non Ionic Linear Gadolinium-Based Contrast Agents
  • 9.6. Global Gadolinium-Based Contrast Agents Market, Sub-Segmentation Of Macrocycle Gadolinium-Based Contrast Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ionic Macrocycle Gadolinium-Based Contrast Agents, Non Ionic Macrocycle Gadolinium-Based Contrast Agents

10. Gadolinium-Based Contrast Agents Market Regional And Country Analysis

  • 10.1. Global Gadolinium-Based Contrast Agents Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Gadolinium-Based Contrast Agents Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gadolinium-Based Contrast Agents Market

  • 11.1. Asia-Pacific Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gadolinium-Based Contrast Agents Market

  • 12.1. China Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gadolinium-Based Contrast Agents Market

  • 13.1. India Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gadolinium-Based Contrast Agents Market

  • 14.1. Japan Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gadolinium-Based Contrast Agents Market

  • 15.1. Australia Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gadolinium-Based Contrast Agents Market

  • 16.1. Indonesia Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gadolinium-Based Contrast Agents Market

  • 17.1. South Korea Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gadolinium-Based Contrast Agents Market

  • 18.1. Taiwan Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gadolinium-Based Contrast Agents Market

  • 19.1. South East Asia Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gadolinium-Based Contrast Agents Market

  • 20.1. Western Europe Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gadolinium-Based Contrast Agents Market

  • 21.1. UK Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gadolinium-Based Contrast Agents Market

  • 22.1. Germany Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gadolinium-Based Contrast Agents Market

  • 23.1. France Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gadolinium-Based Contrast Agents Market

  • 24.1. Italy Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gadolinium-Based Contrast Agents Market

  • 25.1. Spain Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gadolinium-Based Contrast Agents Market

  • 26.1. Eastern Europe Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gadolinium-Based Contrast Agents Market

  • 27.1. Russia Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gadolinium-Based Contrast Agents Market

  • 28.1. North America Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gadolinium-Based Contrast Agents Market

  • 29.1. USA Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gadolinium-Based Contrast Agents Market

  • 30.1. Canada Gadolinium-Based Contrast Agents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gadolinium-Based Contrast Agents Market

  • 31.1. South America Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gadolinium-Based Contrast Agents Market

  • 32.1. Brazil Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gadolinium-Based Contrast Agents Market

  • 33.1. Middle East Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gadolinium-Based Contrast Agents Market

  • 34.1. Africa Gadolinium-Based Contrast Agents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Gadolinium-Based Contrast Agents Market, Segmentation By Type, Segmentation By Magnetic Resonance Imaging (MRI) Procedure Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gadolinium-Based Contrast Agents Market Regulatory and Investment Landscape

36. Gadolinium-Based Contrast Agents Market Competitive Landscape And Company Profiles

  • 36.1. Gadolinium-Based Contrast Agents Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Gadolinium-Based Contrast Agents Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Gadolinium-Based Contrast Agents Market Company Profiles
    • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medline Imaging Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. United Imaging Healthcare Overview, Products and Services, Strategy and Financial Analysis

37. Gadolinium-Based Contrast Agents Market Other Major And Innovative Companies

  • J.B. Chemicals & Pharmaceuticals Ltd., iMax Diagnostic Imaging Ltd., Zhejiang Starry Pharmaceutical Co. Ltd., Trivitron Diagnostic Imaging R&D, Canon Medical Systems Corporation, Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Vision Pharma Pvt. Ltd., Livealth Biopharma Pvt. Ltd., China Resources Zizhu Pharmaceutical Co. Ltd., Kiran Medical Systems Ltd., Unispire Biopharma Pvt. Ltd.

38. Global Gadolinium-Based Contrast Agents Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gadolinium-Based Contrast Agents Market

40. Gadolinium-Based Contrast Agents Market High Potential Countries, Segments and Strategies

  • 40.1 Gadolinium-Based Contrast Agents Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Gadolinium-Based Contrast Agents Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Gadolinium-Based Contrast Agents Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer